ebomi
Colour theme
Sign in
Insider · CIK 0001352546

Flynn James E

CIK 0001352546 Name as filed on the most recent filing

Filed as Flynn James E (269)

1,449 transaction lines · from 269 filings · filed 2006-02-08 to 2026-03-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

10 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-01-07 S, Open-market sale Lumos Pharma, Inc.LUMO 2 lines 396,821, disposed Open Form 4 filing 0001193805-21-000029
2021-01-06 S, Open-market sale Lumos Pharma, Inc.LUMO 2 lines 652,703, disposed Open Form 4 filing 0001193805-21-000029
2020-10-06 P, Open-market purchase Oncorus, Inc.ONCR 3 lines 15,000,000, acquired Open Form 4 filing 0001193805-20-001260
2020-09-29 P, Open-market purchase Graybug Vision, Inc.GRAY 25,000,000, acquired Open Form 4 filing 0001193805-20-001220
2020-08-10 P, Open-market purchase Acutus Medical, Inc.AFIB 2 lines 27,000,000, acquired Open Form 4 filing 0001193805-20-001016
2020-07-28 P, Open-market purchase Annexon, Inc.ANNX 2 lines 11,900,000, acquired Open Form 4 filing 0001193805-20-000896
2020-07-14 P, Open-market purchase Nkarta, Inc.NKTX 2 lines 18,000,000, acquired Open Form 4 filing 0001193805-20-000837
2020-06-16 P, Open-market purchase Generation Bio Co.GBIO 4,275,000, acquired Open Form 4 filing 0001193805-20-000694
2020-02-18 P, Open-market purchase Revolution Medicines, Inc.RVMD 2 lines 10,200,000, acquired Open Form 4 filing 0001193805-20-000225
2020-02-10 P, Open-market purchase Schrodinger, Inc.SDGR 4,250,000, acquired Open Form 4 filing 0001193805-20-000122
2020-02-03 P, Open-market purchase Black Diamond Therapeutics, Inc.BDTX 7,600,000, acquired Open Form 4 filing 0001193805-20-000091
2020-01-30 S, Open-market sale Homology Medicines, Inc.FIXX 7,879,037, disposed Open Form 4 filing 0001193805-20-000087
2020-01-29 S, Open-market sale Homology Medicines, Inc.FIXX 136,808, disposed Open Form 4 filing 0001193805-20-000087
2020-01-28 S, Open-market sale Homology Medicines, Inc.FIXX 1,021,936, disposed Open Form 4 filing 0001193805-20-000076
2020-01-27 S, Open-market sale Homology Medicines, Inc.FIXX 3,049,600, disposed Open Form 4 filing 0001193805-20-000076
2020-01-24 S, Open-market sale Homology Medicines, Inc.FIXX 5,965,000, disposed Open Form 4 filing 0001193805-20-000076
2019-12-24 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 7,682,535, disposed Open Form 4 filing 0001193805-19-001981
2019-12-23 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 2,859,193, disposed Open Form 4 filing 0001193805-19-001976
2019-12-20 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 454,278, disposed Open Form 4 filing 0001193805-19-001976
2019-12-19 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 273,589, disposed Open Form 4 filing 0001193805-19-001976
2019-10-29 P, Open-market purchase Cabaletta Bio, Inc.CABA 7,700,000, acquired Open Form 4 filing 0001193805-19-001376
2019-10-07 P, Open-market purchase Frequency Therapeutics, Inc.FREQ 3,999,996, acquired Open Form 4 filing 0001193805-19-000911
2019-07-22 P, Open-market purchase Mirum Pharmaceuticals, Inc.MIRM 2 lines 4,980,000, acquired Open Form 4 filing 0001193805-19-000660
2019-06-27 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 1,882,077, disposed Open Form 4 filing 0001193805-19-000616
2019-06-26 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 7,671, disposed Open Form 4 filing 0001193805-19-000603
2019-06-25 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 232,136, disposed Open Form 4 filing 0001193805-19-000599
2019-06-24 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 286,003, disposed Open Form 4 filing 0001193805-19-000599
2019-06-21 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 1,567,099, disposed Open Form 4 filing 0001193805-19-000599
2019-05-10 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 1,092,274, disposed Open Form 4 filing 0001193805-19-000485
2019-05-09 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 2,673,248, disposed Open Form 4 filing 0001193805-19-000485

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Flynn James E, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001352546

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.